Canopy Growth (WEED.TO, CGC) will supply four Canadian-grown medical cannabis flower strains for distribution in the United Kingdom, it said in a statement on Tuesday.
The company's Canadian-grown flower strains will be supplied to a manufacturer and distributor of prescribed cannabis-based medicines across Europe, GROW Group U.K. Ltd. This will commercialize the products in the UK under Canopy Growth's global Spectrum Therapeutics medical brand, it added.
Shares of the company were last seen up 3.5% at CA$1.345 on the Toronto Stock Exchange.
Price: $1.35, Change: $+0.05, Percent Change: +3.85%